Yao-jie Pan

209 Tong Shan Road
Xuzhou, 221004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications.

Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications.

Journal: Frontiers in pharmacology

Published: March 22, 2025

PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma.

PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma.

Journal: Cellular signalling

Published: April 13, 2023

HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.

HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.

Journal: Pharmacological research

Published: March 22, 2023

Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.

Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.

Journal: Clinical and translational medicine

Published: August 28, 2022

The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application.

The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application.

Journal: DNA and cell biology

Published: August 10, 2022

Author Correction: Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt.

Author Correction: Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt.

Journal: Scientific reports

Published: July 16, 2021

MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.

MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.

Journal: Journal of biomedical science

Published: January 17, 2021

MiR-326: Promising Biomarker for Cancer.

MiR-326: Promising Biomarker for Cancer.

Journal: Cancer management and research

Published: July 19, 2019

PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.

PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.

Journal: Cell death and differentiation

Published: March 01, 2018

PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.

PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 01, 2017

MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.

MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.

Journal: Cell death & disease

Published: June 29, 2017

Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt.

Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt.

Journal: Scientific reports

Published: October 31, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026